טוען...
Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer
Introduction: The integration of diagnostic testing for the presence of a molecular target is of interest to predict successful targeted radionuclide therapy (TRNT). This so-called ‘theranostic’ approach aims to improve personalized treatment based on the molecular characteristics of cancer cells. M...
שמור ב:
| הוצא לאור ב: | Expert Opin Drug Deliv |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Taylor & Francis
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4245996/ https://ncbi.nlm.nih.gov/pubmed/25035968 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/17425247.2014.941803 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|